beta2AR agonist 4 (compound A19) is an effective selective agonist for the beta2-adrenoceptor (beta2-Adrenoceptor), exhibiting an EC50 of 3.7 pM. In a rat model with COPD, beta2AR agonist 4 reduces the elevation of inflammatory factors and leukocytes, thereby improving lung function.
Formel:
C19H23ClN2O5
Target-Kategorie:
Adrenergic Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
